Victoria University

A Phase 1 Dose Escalation Trial of Third Generation Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed and Refractory B-Cell Non Hodgkin Lymphoma

ResearchArchive/Manakin Repository

Files in this item

This item appears in the following Collection(s) Except where otherwise noted, this item's license is described as

Search ResearchArchive

Advanced Search


My Account